Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: B01AC30

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)(clopidogrel;acetylsalicylic acid)

Acute Coronary Syndrome;Myocardial Infarction

Marketing Authorisation Holder: Sanofi-Aventis Groupe

EMA Authorisation: 14/03/2010

INN: clopidogrel;acetylsalicylic acid

Indication

Acute Coronary Syndrome Myocardial Infarction

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.